Compartir
prostaglandin e1: new aspects on pharmacology, metabolism and clinical efficacy (en Inglés)
Curt Diehm
(Ilustrado por)
·
Helmut Sinzinger
(Ilustrado por)
·
Waltraud Rogatti
(Ilustrado por)
·
Springer
· Tapa Blanda
prostaglandin e1: new aspects on pharmacology, metabolism and clinical efficacy (en Inglés) - Diehm, Curt ; Sinzinger, Helmut ; Rogatti, Waltraud
$ 104.20
$ 109.99
Ahorras: $ 5.79
Elige la lista en la que quieres agregar tu producto o crea una nueva lista
✓ Producto agregado correctamente a la lista de deseos.
Ir a Mis ListasSe enviará desde nuestra bodega entre el
Lunes 01 de Julio y el
Martes 02 de Julio.
Lo recibirás en cualquier lugar de Estados Unidos entre 1 y 3 días hábiles luego del envío.
Reseña del libro "prostaglandin e1: new aspects on pharmacology, metabolism and clinical efficacy (en Inglés)"
Although prostaglandin El (PGE ) has been clinically available for a long 1 time, only in recent years has its effectiveness in peripheral arterial occlusive disease been confirmed in controlled studies. Not surprisingly, the favour- able results achieved both in patients with critical limb ischaemia and in those with intermittent claudication has stimulated research activities into the clinical pharmacology of this prostaglandin. As a consequence of these efforts, exciting new findings have revealed that PGE has anti thrombotic, endothelium-stabilizing and leucocyte-stabi- 1 lizing properties as well as effects on lipid metabolism, all of which, quite apart from its well-known anti-aggregating and vasodilator effects, may add to the clinical efficacy of the substance. New data have also been gathered on the metabolism of PGE most b notably the detection of 13,14-dihydro-PGE a metabolite which was b recently isolated in humans following the administration of PGE . Being 1 biologically active, the pharmacodynamic spectrum of 13,14-dihydro-PGE 1 very closely resembles that of PGE . This finding may help to explain the 1 efficacy of PGE despite its rapid metabolization when given intravenously.